An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
Clinical trial NCT02063789 · COMPLETED
Trial details
- NCT number
- NCT02063789
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-04-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.